Related Experiment Video
Updated: Jun 15, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Transcription factor ZBP-89 in cancer growth and apoptosis
Chris Z Y Zhang1, George G Chen, Paul B S Lai
1Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong.
Abstract:
ZBP-89, a Krüppel-type zinc-finger transcription factor that binds to GC-rich sequences, is involved in the regulation of cell growth and cell death. It maps to chromosome 3q21 and is composed of 794 residues. Having bifunctional regulatory domains, ZBP-89 may function as a transcriptional activator or repressor of variety of genes such as p16 and vimentin. ZBP-89 arrests cell proliferation through its interactions with p53 and p21(waf1). It is able to stabilize p53 through directly binding and enhance p53 transcriptional activity by retaining it in the nucleus. In addition, ZBP-89 potentiates in butyrate-induced endogenous p21(waf1) up-regulation. ZBP-89 is usually over-expressed in human cancer cells, where it can efficiently induce apoptosis through p53-dependent and -independent mechanisms. Moreover, ZBP-89 is capable of enhancing killing effects of several anti-cancer drugs. Therefore, ZBP-89 may be served as a potential target in cancer therapy.
Insights
Zinc-binding protein 89 (ZBP-89) regulates cell growth and death, impacting cancer cell proliferation and apoptosis. Overexpressed ZBP-89 in human cancers offers a potential therapeutic target for cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- ZBP-89 is a Krüppel-type zinc-finger transcription factor regulating cell growth and death.
- It interacts with key cell cycle regulators like p53 and p21(waf1).
Purpose of the Study:
- To investigate the role of ZBP-89 in cell proliferation, apoptosis, and cancer.
- To explore ZBP-89 as a potential therapeutic target in cancer therapy.
Main Methods:
- Analysis of ZBP-89's interactions with p53 and p21(waf1).
- Assessment of ZBP-89's effect on gene expression (e.g., p16, vimentin).
- Evaluation of ZBP-89's role in cancer cell apoptosis and drug sensitivity.
Main Results:
- ZBP-89 stabilizes p53, enhances its nuclear retention and transcriptional activity.
- It potentiates butyrate-induced p21(waf1) up-regulation.
- Overexpressed ZBP-89 induces apoptosis via p53-dependent and -independent pathways and enhances anti-cancer drug efficacy.
Conclusions:
- ZBP-89 plays a critical role in cell cycle regulation and apoptosis.
- Its overexpression in cancer suggests ZBP-89 is a promising therapeutic target for novel cancer treatments.
More Related Videos
03:37Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
Published on: March 1, 2024
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Related Concept Videos
The Intrinsic Apoptotic Pathway
General Transcription Factors
Transcription Factors
Transcription Factors
Abnormal Proliferation
Negative Regulator Molecules